Simple Science

Cutting edge science explained simply

# Biology # Genetics

Gene Editing: A New Hope for Genetic Disorders

Exploring gene editing techniques and their potential to treat genetic disorders.

Poorvi H. Dua, Bazilco M. J. Simon, Chiara B.E. Marley, Carissa M. Feliciano, Hannah L. Watry, Dylan Steury, Abin Abraham, Erin N. Gilbertson, Grace D. Ramey, John A. Capra, Bruce R. Conklin, Luke M. Judge

― 6 min read


Gene Editing: Tackling Gene Editing: Tackling Genetic Disorders for treating genetic diseases. New gene editing methods show promise
Table of Contents

Gene editing is the process of altering DNA to improve or change the way genes work. You can think of it as trying to fix a typo in a book. If a word is misspelled, the reader may misunderstand the text. Similarly, if a gene has a mistake, it can lead to health problems. Scientists are working hard to find ways to edit genes in order to treat genetic disorders.

The Basics of Gene Editing

One of the most popular tools for gene editing is called CRISPR, which sounds like a snack food brand but is actually a clever technique for making precise changes in DNA. Imagine having a pair of scissors that can cut DNA at specific locations. CRISPR uses a guide to find the right spot, and then the scissors come in to make the cut. Once the DNA is cut, the cell will try to fix the break. We can use this repair process to change the gene's function.

Heredity and Genetic Disorders

Genetic disorders can be passed down from parents to children. Some disorders are caused by just one faulty gene, while others come from many genetic changes. When a person has two copies of a gene, one from mom and one from dad, that’s called having two Alleles. Sometimes, one allele is normal, and the other is not. If the unhealthy allele is the one that gets expressed, it can lead to illness.

Dominant vs. Recessive Traits

In genetics, we often talk about dominant and recessive traits. If a disorder is caused by a dominant allele, a single copy of that allele can cause a disorder. Think of it like a light switch: one switch being flipped can turn on a light. On the flip side, recessive disorders usually require both alleles to be faulty. It’s like needing two switches to cooperate to turn on a light.

For example, let’s talk about Charcot-Marie-Tooth disease type 2E (CMT2E). It’s caused by a mutation in a gene called NEFL. If a person inherits a faulty NEFL gene from one parent, they may develop symptoms of CMT2E. However, if they inherit a normal version from the other parent, they might be okay. This is because the normal version can do the job just fine.

The Challenge of Targeting Specific Mutations

When scientists try to edit genes to fix these disorders, they face a challenge. The same gene can have many different mutations, making it hard to create one-size-fits-all solutions. CMT2E is tricky because it can be caused by over 50 different mutations in the NEFL gene. Imagine if you had to spell-check a book with hundreds of typos! You'd be there all day trying to fix them all one at a time.

Scientists want to find a way to create treatments that could work for many people with similar issues, rather than designing a unique solution for each person. This is where the idea of “haplotype editing” comes in. Haplotype editing tries to target certain groups of genetic changes that are often found together, making it more efficient.

Haplotype Editing: A Clever Trick

The concept of haplotype editing is like getting a two-for-one deal at a store. Instead of hunting down and fixing every single typo, you identify the common patterns of errors and fix them all at once. Scientists can look for common genetic variants (think of them as friendly neighborhood markers) that surround the faulty genes.

For instance, they might find two common genetic markers near the NEFL gene. By targeting these markers, they can stitch together fixes for the troublesome alleles (the faulty genetic changes) without having to address each unique mutation individually.

The Research Journey

Researchers are conducting studies to see how effective this haplotype editing approach can be. They use cells derived from patients with CMT2E to test their methods. By using these cells in lab experiments, scientists can assess if their gene editing techniques successfully reduce harmful traits associated with the disease.

When they use CRISPR with pairs of markers, they can achieve a significant level of success. By excising or, in simpler terms, cutting out the faulty gene sections, researchers have been able to produce promising results.

The Power of Practicality

One of the major advantages of this approach is that it significantly cuts down on the number of unique therapies needed. If each mutation required a separate treatment, it would be like trying to sell a unique flavor of ice cream for every single person. By using common markers, scientists can create a more streamlined approach, similar to offering just a few classic flavors rather than hundreds of unique ones.

Moving Forward

This research doesn't just stop with NEFL and CMT2E. It has implications for other genetic disorders too. The hope is that if scientists can successfully generalize their techniques, they can adapt this strategy to tackle multiple diseases.

This means that patients with various genetic disorders caused by dominant mutations might benefit from a similar strategy, making the quest for effective treatments a lot more feasible.

The Road Ahead

As researchers refine their methods, they are particularly interested in ensuring that their approaches are safe and effective. The object is not just to cut out the faults but also to avoid causing any unintended damage to other parts of the genome. Off-target effects, where gene editing inadvertently alters the wrong part of the DNA, need to be minimized.

Researchers are continuously working on improving their techniques, including ways to boost efficiency, precision, and specificity. For example, adding a small piece of DNA alongside the editing tools can help drive better results, much like adding a secret ingredient to a recipe can enhance its flavor.

The Future of Gene Editing

Gene editing holds immense promise for the future of medicine. It has the potential to change lives by correcting the genetic mistakes that cause so much suffering. But like any great journey, it requires patience, diligence, and constant learning.

In conclusion, while gene editing might seem like science fiction today, it offers a beacon of hope for many people affected by genetic disorders. With creative approaches like haplotype editing, researchers are making strides toward solutions that could help countless individuals-proving that sometimes, all it takes is a little creativity to bring about monumental change. So, next time you think about genetics, remember: it’s not just about the letters in a book; it’s about making sure the story ends well.

Original Source

Title: Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL

Abstract: Inactivation of disease alleles by allele-specific editing is a promising approach to treat dominant-negative genetic disorders, provided the causative gene is haplo-sufficient. We previously edited a dominant NEFL missense mutation with inactivating frameshifts and rescued disease-relevant phenotypes in induced pluripotent stem cell (iPSC)-derived motor neurons. However, a multitude of different NEFL missense mutations cause disease. Here, we addressed this challenge by targeting common single-nucleotide polymorphisms in cis with NEFL disease mutations for gene excision. We validated this haplotype editing approach for two different missense mutations and demonstrated its therapeutic potential in iPSC-motor neurons. Surprisingly, our analysis revealed that gene inversion, a frequent byproduct of excision editing, failed to reliably disrupt mutant allele expression. We deployed alternative strategies and novel molecular assays to increase therapeutic editing outcomes while maintaining specificity for the mutant allele. Finally, population genetics analysis demonstrated the power of haplotype editing to enable therapeutic development for the greatest number of patients. Our data serve as an important case study for many dominant genetic disorders amenable to this approach.

Authors: Poorvi H. Dua, Bazilco M. J. Simon, Chiara B.E. Marley, Carissa M. Feliciano, Hannah L. Watry, Dylan Steury, Abin Abraham, Erin N. Gilbertson, Grace D. Ramey, John A. Capra, Bruce R. Conklin, Luke M. Judge

Last Update: Dec 22, 2024

Language: English

Source URL: https://www.biorxiv.org/content/10.1101/2024.12.20.629813

Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.20.629813.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to biorxiv for use of its open access interoperability.

Similar Articles